NO20091420L - Selektiv kjemokinmodulering - Google Patents

Selektiv kjemokinmodulering

Info

Publication number
NO20091420L
NO20091420L NO20091420A NO20091420A NO20091420L NO 20091420 L NO20091420 L NO 20091420L NO 20091420 A NO20091420 A NO 20091420A NO 20091420 A NO20091420 A NO 20091420A NO 20091420 L NO20091420 L NO 20091420L
Authority
NO
Norway
Prior art keywords
metal
oxide
present
selective chemokine
chemokine modulation
Prior art date
Application number
NO20091420A
Other languages
English (en)
Other versions
NO341876B1 (no
Inventor
Lars Bruce
Stale Petter Lyngstadaas
Original Assignee
Prophymed Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39184028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20091420(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Prophymed Ab filed Critical Prophymed Ab
Publication of NO20091420L publication Critical patent/NO20091420L/no
Publication of NO341876B1 publication Critical patent/NO341876B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/06—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising oxides or hydroxides of metals not provided for in group B01J20/04
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Den foreliggende oppfinnelsen involvere bruk av et metall eller et metalloksid som har kapasitet til å binde IP-10 til sin overflate. Metall (oksidet) har videre en IP-10 nedregulerende effekt ved at en kontakt mellom metalloverflata og en IP-10 produserende celle vil forårsake en reduksjon i IP-10 produksjonen i den cellen. Metallet eller metalloksidet i samsvar med den foreliggende oppfinnelsen er et metall av gruppe 4 eller 5 i det periodiske systemet. Mer foretrukket er metallet et oksid av titan, så som titandioksid. Metallene og metalloksidene i samsvar med foreliggende oppfinnelse kan benyttes for å framstille et medikament for behandling eller forebygging av en sykdom karakterisert ved skadelig ekspresjon og/eller frigivelse av IP-10.
NO20091420A 2006-09-12 2009-04-07 Anvendelse av et metall eller et oksid av et metall i framstillingen av et medikament, og anordning i form av en sprøyte for rensing av kroppsvæske og anvendelse av samme NO341876B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84376006P 2006-09-12 2006-09-12
PCT/SE2007/000785 WO2008033069A1 (en) 2006-09-12 2007-09-11 Selective chemokine modulation

Publications (2)

Publication Number Publication Date
NO20091420L true NO20091420L (no) 2009-06-11
NO341876B1 NO341876B1 (no) 2018-02-12

Family

ID=39184028

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20091420A NO341876B1 (no) 2006-09-12 2009-04-07 Anvendelse av et metall eller et oksid av et metall i framstillingen av et medikament, og anordning i form av en sprøyte for rensing av kroppsvæske og anvendelse av samme

Country Status (17)

Country Link
US (3) US8784845B2 (no)
EP (1) EP2068895B1 (no)
JP (1) JP5290179B2 (no)
KR (1) KR101419963B1 (no)
CN (1) CN101573126B (no)
AU (1) AU2007295138B2 (no)
BR (1) BRPI0716728A2 (no)
CA (1) CA2663259C (no)
ES (1) ES2401031T3 (no)
IL (1) IL197562A (no)
MX (1) MX2009002699A (no)
MY (1) MY148756A (no)
NO (1) NO341876B1 (no)
NZ (1) NZ576190A (no)
RU (1) RU2446809C2 (no)
SG (1) SG174094A1 (no)
WO (1) WO2008033069A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE531319C2 (sv) 2007-02-22 2009-02-24 Tigran Technologies Ab Publ Porös implantatgranul
EP3094642B1 (en) 2013-12-20 2018-03-21 Tikomed AB Surface-binding peptide
CN104020297B (zh) * 2014-06-10 2016-12-07 上海交通大学医学院 用于结核分枝杆菌感染检测及临床治疗效果监测的试剂盒及其用途
JP6631499B2 (ja) * 2016-12-27 2020-01-15 トヨタ自動車株式会社 ハイブリッド車両の制御装置
CA3183415A1 (en) 2020-05-11 2021-11-18 Minnetronix Neuro, Inc. Filtering cassettes and filtering systems

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2252729B (en) * 1991-02-13 1994-11-09 Bharat Sridhar Pancham Vitamin and/or mineral containing pharmaceutical compositions
EP0686848A1 (en) * 1994-05-09 1995-12-13 Shiseido Company Limited Liquid chromatograph having a micro and semi-micro column
CA2280249A1 (en) * 1999-08-12 2001-02-12 Universite Laval Vanadium compounds as anti-angiogenics and as inhibitors of endothelin production
US20030055106A1 (en) * 1999-08-12 2003-03-20 Robert Faure Therapeutic uses of peroxometallic compounds
DE19938668B4 (de) * 1999-08-14 2006-01-26 Bausch & Lomb Inc. Tränenersatzmittel
US6527951B1 (en) * 2000-11-16 2003-03-04 Waters Investments Limited Chromatographic column
US20050119105A1 (en) * 2002-01-18 2005-06-02 Schott Ag Glass-ceramic composite containing nanoparticles
DE10201747C1 (de) 2002-01-18 2003-08-14 Schott Glas Glas-Keramik-Komposit, Verfahren zu seiner Herstellung und Verwendungen
DE112005002839T5 (de) * 2004-11-16 2007-12-20 Waters Investments Ltd., New Castle Vorrichtung zum Durchführen von Auftrennungen und Verfahren zum Herstellen und Verwenden derselben

Also Published As

Publication number Publication date
JP5290179B2 (ja) 2013-09-18
US8784845B2 (en) 2014-07-22
KR101419963B1 (ko) 2014-07-30
US20140302149A1 (en) 2014-10-09
RU2446809C2 (ru) 2012-04-10
IL197562A (en) 2013-12-31
CN101573126A (zh) 2009-11-04
WO2008033069A8 (en) 2009-07-23
ES2401031T3 (es) 2013-04-16
US9649426B2 (en) 2017-05-16
EP2068895A1 (en) 2009-06-17
SG174094A1 (en) 2011-09-29
IL197562A0 (en) 2009-12-24
WO2008033069A1 (en) 2008-03-20
JP2010503666A (ja) 2010-02-04
AU2007295138A1 (en) 2008-03-20
CA2663259A1 (en) 2008-03-20
EP2068895B1 (en) 2012-12-12
MY148756A (en) 2013-05-31
NZ576190A (en) 2011-06-30
BRPI0716728A2 (pt) 2017-06-13
RU2009113579A (ru) 2010-10-20
EP2068895A4 (en) 2009-12-23
AU2007295138B2 (en) 2012-10-04
CA2663259C (en) 2017-01-03
MX2009002699A (es) 2009-06-11
CN101573126B (zh) 2012-04-25
US20100203089A1 (en) 2010-08-12
KR20090069293A (ko) 2009-06-30
US20140299548A1 (en) 2014-10-09
US9656015B2 (en) 2017-05-23
NO341876B1 (no) 2018-02-12

Similar Documents

Publication Publication Date Title
WO2006138394A3 (en) Nanoparticle surface treatment
NO20091420L (no) Selektiv kjemokinmodulering
WO2005012360A3 (en) Binding molecules against sars-coronavirus and uses thereof
DK1984533T3 (da) Krybe-modstandsdygtigt ferritisk stål
ATE488847T1 (de) Kontaktelement
UA91016C2 (ru) носитель катализатора, каталитическая композиция, процессы их приготовления и процесс гидрокрекинга с использованием каталитической композиции
MY144999A (en) Method of preparing microfibrillar polysaccharide
RU2009119712A (ru) Бета-титановый сплав
TWI372792B (zh) 從含有具導電性之氧化物之廢料回收有價金屬之方法
MX350347B (es) Procedimiento para la produccion de un catalizador de zeolita activo para una scr, asi como un catalizador de zeolita activo para una scr.
WO2009097082A8 (en) Spray-dried transition metal zeolite and its use
ATE484603T1 (de) Legierung auf der basis von nickel und deren verwendung für zündkerzenelektroden
SA522433328B1 (ar) تركيبة محفز تحتوي على نيكل ذو حموضة محسنة لعمليات إعادة التشكيل الجافة
JP2005501968A5 (no)
GB0612094D0 (en) Electrode, method of manufacture and use thereof
TW200503830A (en) Catalyst for steam reforming of methanol and process for producing thereof
JP2008542549A5 (no)
RU2011122786A (ru) Добавление алюмината лития для улучшения характеристик самозащитных электродов
MX2010001586A (es) Estructuras de dimensiones nanometricas compuestas de metales de valvula y suboxidos de metales de valvula y proceso para producirlas.
TW200519040A (en) Process for removing water from ammonia
TW200716159A (en) Method of use of antagonists of zonulin to prevent the loss of or to regenerate pancreatic cells
TW200500135A (en) Desulfurizing agent and method for production thereof, method for desulfurization, and method for producing hydrogen for fuel cell
CN202534548U (zh) 一种低压开关操作手柄
PH12022553605A1 (en) A personal care composition comprising atractylenolide-i or a source thereof
CN103602864A (zh) 一种镁基合金

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees